Omeprazole tablets bulk supplier for pharma manufacturers

Omeprazole Tablets 20 mg, 40 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 20 mg, 40 mg

Reference Brands: Prilosec(US & EU)

Omeprazole tablets work by irreversibly inhibiting the gastric H⁺/K⁺ ATPase enzyme in stomach lining cells, reducing acid production. Benefits include relief from acid reflux, gastroesophageal reflux disease (GERD), and ulcers, promoting healing of the esophagus and stomach, and preventing acid-related damage and discomfort.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Omeprazole tablets are approved in both the US and EU, with regulatory oversight from the FDA and EMA. These products are supported by detailed dossiers demonstrating safety, efficacy, and manufacturing quality under GMP standards. In the US, Prilosec is a leading branded formulation, while in the EU, generic and branded versions like Losec are common. Regulatory approval involves rigorous clinical evaluation and documentation. For comprehensive information on licensing, approved dossiers, and regulatory requirements for omeprazole tablets, visit Pharmatradz. Stay updated on the latest regulatory developments and licensing processes for omeprazole in global markets.

Omeprazole Tablets — third party manufacturing & bulk supply

Omeprazole Tablets 20 mg, 40 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Omeprazole Tablets is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Omeprazole Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Omeprazole Tablets →

Back to Listing

Frequently Asked Questions

Omeprazole is used to treat conditions caused by excess stomach acid such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. It helps relieve symptoms like heartburn, difficulty swallowing, and persistent cough by reducing the amount of acid produced in the stomach and promoting healing of acid-related damage to the esophagus and stomach lining.

Omeprazole tablets contain the active ingredient omeprazole, which is a proton pump inhibitor (PPI). It is made using synthetic chemical synthesis and formulated with excipients such as lactose, magnesium stearate, sodium lauryl sulfate, and hypromellose to ensure proper absorption and tablet stability.

Common trade names of Omeprazole include Prilosec, Losec, Omez, and Zegerid.

Omeprazole was originally developed and marketed by AstraZeneca under the brand name Losec (Prilosec in the USA). Today, it is produced by multiple pharmaceutical companies worldwide, including Dr. Reddy’s Laboratories, Sun Pharma, and Teva Pharmaceuticals, as a widely available generic medicine.

The generic name of the product is Omeprazole.

The brand names of the product are Prilosec, Losec, Omez, and Zegerid.

Omeprazole is manufactured globally by several companies. AstraZeneca manufactures it in Sweden and the UK for its branded versions, while generic Omeprazole tablets are produced in countries such as India, the USA, and Canada by leading pharmaceutical manufacturers.